Oliver Baumann
Förmögenhet: 8 M $ per 2026-08-31
Förmögenhet: 8 M $ per 2026-08-31
Oliver R.
Baumann is Chief Executive Officer & Director at Xlife Sciences AG since 2020, Chief Executive Officer at Akira Trading GmbH, Chairman at Akira Holding AG, Chairman & General Manager at Veraxa Biotech Holding AG, Director at Pecunia Solutions AG, Director at VERAXA Biotech AG, Director at Axenoll Life Sciences AG, and Co-Managing Director at Xrna.
Biotech GmbH.
Former roles include Chief Executive Officer at Belvoir Wealth Management AG and Co-Managing Director at x-diagnostics GmbH.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
4,08 % | 2026-08-27 | 5 773 618 ( 4,08 % ) | 8 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| XLIFE SCIENCES AG | Verkställande Direktör | 2019-07-01 |
Pecunia Solutions AG | Direktör/Styrelseledamot | - |
Axenoll Life Sciences AG | Direktör/Styrelseledamot | - |
Akira Holding AG | Ordförande | - |
| Företag | Position | Slut |
|---|---|---|
Veraxa Biotech AG
Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Direktör/Styrelseledamot | - |
Belvoir Wealth Management AG
Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Belvoir Wealth Management AG
Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Finance |
Pecunia Solutions AG | |
Xlife Sciences AG
Xlife Sciences AG Miscellaneous Commercial ServicesCommercial Services Develops life sciences technologies | Commercial Services |
Akira Holding AG | |
Veraxa Biotech AG
Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Health Technology |
Axenoll Life Sciences AG |
Välj din utgåva
All finansiell information anpassad till den nationella nivån